These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37124845)

  • 1. Pattern of drug resistant
    Ansarin K; Sahebi L
    Iran J Microbiol; 2022 Jun; 14(3):285-290. PubMed ID: 37124845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review.
    Pourakbari B; Mamishi S; Mohammadzadeh M; Mahmoudi S
    Front Microbiol; 2016; 7():1139. PubMed ID: 27516756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
    Lukoye D; Ssengooba W; Musisi K; Kasule GW; Cobelens FG; Joloba M; Gomez GB
    BMC Public Health; 2015 Mar; 15():291. PubMed ID: 25880829
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Reta MA; Tamene BA; Abate BB; Mensah E; Maningi NE; Fourie PB
    Trop Med Infect Dis; 2022 Oct; 7(10):. PubMed ID: 36288041
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug resistance pattern of Mycobacterium tuberculosis isolates from patients of five provinces of Iran.
    Nasiri MJ; Rezaei F; Zamani S; Darban-Sarokhalil D; Fooladi AA; Shojaei H; Feizabadi MM
    Asian Pac J Trop Med; 2014 Mar; 7(3):193-6. PubMed ID: 24507638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran.
    Nasiri MJ; Zamani S; Pormohammad A; Feizabadi MM; Aslani HR; Amin M; Halabian R; Imani Fooladi AA
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):9-14. PubMed ID: 28823010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence and transmission of pyrazinamide-resistant
    Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376
    [No Abstract]   [Full Text] [Related]  

  • 8. Isoniazid-resistant tuberculosis in Iran: A systematic review.
    Javad Nasiri M; Chirani AS; Amin M; Halabian R; Imani Fooladi AA
    Tuberculosis (Edinb); 2016 May; 98():104-9. PubMed ID: 27156625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis of the Beijing Genotype in Iran and the World Health Organization Eastern Mediterranean Region: A Meta-Analysis.
    Hoffner S; Sahebi L; Ansarin K; Sabour S; Mohajeri P
    Microb Drug Resist; 2018; 24(6):693-698. PubMed ID: 29058526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Report on Drug Resistance Patterns of
    Mansoori N; Pahlavanzadeh B; Atarjalali M
    Arch Iran Med; 2022 Mar; 25(3):161-165. PubMed ID: 35429957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and patterns of drug-resistant Mycobacterium tuberculosis in newly diagnosed patients in China: A systematic review and meta-analysis.
    Jin C; Wu Y; Chen J; Liu J; Zhang H; Qian Q; Pang T
    J Glob Antimicrob Resist; 2024 May; 38():292-301. PubMed ID: 38825149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of drug-resistant tuberculosis in Iran: systematic review and meta-analysis.
    Nasiri MJ; Dabiri H; Darban-Sarokhalil D; Rezadehbashi M; Zamani S
    Am J Infect Control; 2014 Nov; 42(11):1212-8. PubMed ID: 25242634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity and drug resistance pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia.
    Lobie TA; Woldeamanuel Y; Asrat D; Beyene D; Bjørås M; Aseffa A
    PLoS One; 2020; 15(4):e0231320. PubMed ID: 32267877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of drug resistance-conferring mutations associated with isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Ethiopia: a systematic review and meta-analysis.
    Reta MA; Alemnew B; Abate BB; Fourie PB
    J Glob Antimicrob Resist; 2021 Sep; 26():207-218. PubMed ID: 34214698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia.
    Biadglegne F; Tessema B; Sack U; Rodloff AC
    Indian J Med Res; 2014 Jul; 140(1):116-22. PubMed ID: 25222786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An updated systematic review and meta-analysis on
    Khademi F; Sahebkar A
    Iran J Basic Med Sci; 2021 Apr; 24(4):428-436. PubMed ID: 34094023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    BMC Infect Dis; 2012 Feb; 12():37. PubMed ID: 22325147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.